Higher expression of IL-12Rβ2 is associated with lower risk of relapse in relapsing–remitting multiple sclerosis patients on interferon-β1b therapy during 3-year follow-up

Rezultati

Naziv:	Higher expression of IL-12Rβ2 is associated with lower risk of relapse in relapsing–remitting multiple sclerosis patients on interferon-β1b therapy during 3-year follow-up
Autori:	Milošević, Emina ; Dujmović, Irena ; Marković, Miloš ; Mesaroš, Šarlota ; Rakočević, Goran ; Drulović, Jelena ; Mostarica-Stojković, Marija ; Popadić, Dušan
Godina:	2015
Publikacija:	Journal of neuroimmunology
ISSN:	0165-5728 Journal of Neuroimmunology Pretraži identifikator
Izdavač:	[Amsterdam] : Elsevier/North-Holland
Tip rezultata:	Naučni članak
Kolacija:	vol. 287 str. 64-70
DOI:	10.1016/j.jneuroim.2015.07.011
WoS-ID:	000363347300011
Scopus-ID:	2-s2.0-84943241789
PMID:	26439963
URI:	https://enauka.gov.rs/handle/123456789/224775
URL:	https://www.sciencedirect.com/science/article/pii/S0165572815300138?via%3Dihub
Izvor metapodataka:	Migrirano iz RIS podataka
M-kategorija:	22M22 - Međunarodni časopis kategorije M22

6
SCOPUS^TM

1
PubMed Central^TM

4
OpenCitations

4
WEB OF SCIENCE^TM

Alt metrika

Dimensions

Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.